KODIAK SCIENCES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.28 USD | +2.98% |
|
-2.38% | +7.89% |
| 04-04 | UBS Adjusts Kodiak Sciences Price Target to $5 From $3, Maintains Neutral Rating | MT |
| 04-01 | Barclays Raises Price Target on Kodiak Sciences to $3 From $2, Maintains Underweight Rating | MT |
Chart calendar Kodiak Sciences Inc.
f395954.plS7BgGgazPZ9M3P0-VMOi7-2dpjltMTFmzzTQW0aTQ.4TzfbzD5P1zgjaP2vad4TWm66rcl8OV1ZF2JFUPHBljBDP1HV9kYWKDN-Q~9977775354d776848feb1ec035eb686b
Upcoming events on Kodiak Sciences Inc.
Past events on Kodiak Sciences Inc.
| 28/03/2024 20:30 | Q4 2023 Earnings Call |
| 28/03/2024 10:30 | Q4 2023 Earnings Release |
| 03/02/2024 20:30 | Angiogenesis, Exudation, and Degeneration Meeting |
| 10/01/2024 15:30 | JPMorgan Healthcare Conference |
| 29/11/2023 20:25 | Evercore ISI HealthCONx Conference |
| 14/11/2023 21:01 | Q3 2023 Earnings Release |
| 03/11/2023 23:56 | American Academy Of Ophthalmology Meeting |
| 13/10/2023 15:38 | The Retina Society Scientific Meeting |
| 13/10/2023 15:28 | The Retina Society Scientific Meeting |
| 13/10/2023 13:52 | The Retina Society Scientific Meeting |
| 13/09/2023 17:55 | Morgan Stanley Global Healthcare Conference |
| 14/08/2023 21:01 | Q2 2023 Earnings Release |
| 30/07/2023 23:51 | American Society of Retina Meeting |
| 15/06/2023 00:40 | Goldman Sachs Global Healthcare Conference |
| 07/06/2023 18:30 | Jefferies Global Healthcare Conference |
| 15/05/2023 21:01 | Q1 2023 Earnings Release |
| 25/04/2023 14:45 | Association for Research in Vision and Ophthalmology Meeting - Poster Number: 2606 - B0319 |
| 24/04/2023 21:15 | Association for Research in Vision and Ophthalmology Meeting - Poster Number: 2215 - C0168 |
| 23/04/2023 21:45 | Association for Research in Vision and Ophthalmology Meeting - Poster Number: 1152 - C0307 |
| 23/04/2023 21:45 | Association for Research in Vision and Ophthalmology Meeting - Poster Number: 1153 - C0308 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 20,0 - | 0,00 20,8 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -48,7 -50,0 2.61% | -136 -121 -11.57% | -266 -224 -19.02% | -338 -349 3.29% | -259 -235 -10.13% | -211 |
|
EBIT Million USD | Released Forecast Spread | -49,2 -30,9 -58.96% | -136 -126 -7.52% | -267 -233 -14.78% | -341 -353 3.32% | -277 -262 -5.74% | -227 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -47,4 -46,4 -2.11% | -133 -126 -5.31% | -267 -242 -10.47% | -334 -348 4.02% | -260 -246 -5.72% | -226 |
|
Net income Million USD | Released Forecast Spread | -47,4 -46,4 -2.08% | -133 -126 -5.29% | -267 -242 -10.5% | -334 -348 4.05% | -260 -246 -5.71% | -225 |
|
EPS USD | Released Forecast Spread | -1,25 -1,15 -8.54% | -2,91 -2,65 -9.72% | -5,16 -4,68 -10.31% | -6,39 -6,58 2.83% | -4,97 -4,64 -7.09% | -4,08 |
| Announcement Date | 16/03/20 | 01/03/21 | 01/03/22 | 28/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBIT Million USD | Released Forecast Spread | -93,0 -72,1 -29.08% | -95,8 -80,6 -18.79% | -92,1 -93,0 0.96% | -79,5 -95,9 17.1% | -74,1 -83,2 10.96% | -74,6 -76,5 2.43% | -84,8 -63,8 -32.88% | -54,5 -76,4 28.63% | -63,4 -48,5 -30.67% | -57,6 | -56,3 | -56,2 | -56,6 | -48,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -93,2 -67,4 -38.21% | -95,7 -72,6 -31.89% | -90,6 -91,0 0.45% | -77,0 -91,6 15.85% | -70,4 -80,6 12.55% | -70,8 -72,4 2.2% | -80,2 -61,7 -29.92% | -50,0 -74,2 32.64% | -59,5 -44,9 -32.55% | -56,3 | -53,8 | -52,4 | -51,4 | |
|
Net income Million USD | Released Forecast Spread | -93,2 -67,4 -38.21% | -95,7 -72,6 -31.89% | -90,6 -91,0 0.45% | -77,0 -91,6 15.85% | -70,4 -80,6 12.55% | -70,8 -72,4 2.2% | -80,2 -61,7 -29.92% | -50,0 -74,2 32.64% | -59,5 -44,9 -32.55% | -56,3 | -53,8 | -52,4 | -51,4 | |
|
EPS USD | Released Forecast Spread | -1,79 -1,35 -32.85% | -1,83 -1,56 -17.03% | -1,74 -1,76 1.14% | -1,47 -1,78 17.33% | -1,35 -1,54 12.08% | -1,35 -1,42 4.76% | -1,53 -1,13 -35.51% | -0,95 -1,35 29.54% | -1,13 -0,82 -37.73% | -1,03 | -1,01 | -1,02 | -1,02 | -0,89 |
| Announcement Date | 01/03/22 | 10/05/22 | 09/08/22 | 09/11/22 | 28/03/23 | 15/05/23 | 14/08/23 | 14/11/23 | 28/03/24 | - | - | - | - | - |
More events
Past sector events for Kodiak Sciences Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- KOD Stock
- Calendar Kodiak Sciences Inc.
